Proactive Primary Dementia Care

积极主动的原发性痴呆护理

基本信息

项目摘要

DESCRIPTION (provided by applicant): Dementia, an age-associated clinical syndrome characterized by irreversible loss or decline in memory and other cognitive abilities, is a growing health problem. In 2008, an estimated 5.2 million Americans have Alzheimer's disease (AD), which comprises about 70 percent of all dementia; AD prevalence alone is projected to increase to more than 11 million by 2050. Family members caring for people with dementia often suffer adverse health consequences. Primary care physicians are usually the first contact for older people with memory loss complaints and their families, but substantial evidence shows that physicians face numerous constraints to providing comprehensive dementia care. Several recent randomized controlled trials to enhance primary care for these patients and families have found positive results; however, none has been successfully sustained beyond the study period or replicated in community-based primary care settings. Accordingly, the long range goal of this developmental study is to implement an evidence-based nurse-practitioner guided dementia care intervention, linked to one or more groups of primary care physicians in a defined geographic area, to maximize health-related outcomes in patients with new or recently diagnosed AD or other age-associated dementia and their family caregivers. The proposed 12-month intervention, Proactive Primary Dementia Care (PPDC), is grounded in the Progressively Lowered Stress Threshold model of dementia care, and utilizes evidence-based nonpharmacologic protocols along with medication and comorbidity monitoring in tandem with physicians. Specific aims and major hypotheses are: Specific Aim #1: Determine the preliminary efficacy of PPDC on health-related outcomes in patients and their primary family caregivers. Patient-specific hypotheses: Patients receiving PPDC will show reduced or more stabilized neuropsychiatric symptoms, and improved or more stabilized self-reported quality of life, compared to control group patients. Caregiver-specific hypotheses: Caregivers receiving PPDC will show reduced or more stabilized depressive symptoms and burden, and increased or more stabilized self-efficacy for managing dementia, compared to caregivers in the control group. Specific Aim #2: Determine the acceptability of PPDC to physicians, patients, and caregivers. Specific Aim #3: Examine the preliminary financial sustainability of PPDC. A total of 35 patient-caregiver dyads will be recruited to participate in PPDC from two primary care practice sites; 35 dyads will be recruited for the control group from two different practice sites, and they will receive and review with study personnel educational material about dementia and community resources, and will be encouraged to seek further information and help as they see fit. PUBLIC HEALTH RELEVANCE: Dementia is a public health problem of rapidly growing proportions. Cognitive and behavioral symptoms characteristic of dementia are often extremely stressful to patients and their families. The intervention proposed in this developmental study is based on substantial evidence that primary care physicians require assistance from other health care practitioners to meet the needs of patients and families from the point of diagnosis onward. Evidence-based, theoretically grounded interventions are needed to enhance dementia care in the primary care setting, in a proactive fashion from the time of diagnosis or as soon as possible thereafter, to avoid or alleviate poor health-related outcomes in patients and their family caregivers.
描述(由申请人提供):痴呆症是一种与年龄相关的临床综合征,其特征是记忆和其他认知能力的不可逆转的丧失或下降,是一个日益严重的健康问题。2008年,估计有520万美国人患有阿尔茨海默病(AD),约占所有痴呆症患者的70%;预计到2050年,仅阿尔茨海默病的患病率就将增加到1100多万。照顾痴呆症患者的家庭成员往往会遭受不利的健康后果。初级保健医生通常是有记忆丧失投诉的老年人及其家人的第一个联系人,但大量证据表明,医生在提供全面的痴呆症护理方面面临许多限制。最近几项旨在加强这些患者及其家属初级保健的随机对照试验取得了积极成果;然而,没有一项成功地持续到研究结束后,或在社区初级保健环境中复制。因此,本发展性研究的长期目标是实施以证据为基础的护士-执业医师指导的痴呆护理干预,与特定地理区域的一组或多组初级保健医生相关联,以最大限度地提高新诊断或最近诊断为AD或其他年龄相关痴呆的患者及其家庭护理人员的健康相关结果。提出的为期12个月的干预措施,主动性初级痴呆护理(PPDC),是基于痴呆护理的逐步降低压力阈值模型,并利用循证的非药物方案以及药物和医生的合并症监测。具体目标和主要假设如下:具体目标#1:确定PPDC对患者及其主要家庭照顾者健康相关结局的初步疗效。患者特异性假设:与对照组患者相比,接受PPDC的患者将表现出减轻或更稳定的神经精神症状,并改善或更稳定的自我报告生活质量。照顾者特定假设:与对照组的照顾者相比,接受PPDC的照顾者将表现出减少或更稳定的抑郁症状和负担,并增加或更稳定的管理痴呆的自我效能。具体目标2:确定医生、患者和护理人员对PPDC的接受程度。具体目标3:检查PPDC的初步财务可持续性。将从两个初级保健实践地点招募35名患者-护理人员对参加PPDC;将从两个不同的练习地点招募35对夫妇作为对照组,他们将与研究人员一起接受和审查有关痴呆症的教育材料和社区资源,并鼓励他们寻求进一步的信息和帮助,因为他们认为合适。公共卫生相关性:痴呆症是一个比例迅速增长的公共卫生问题。痴呆症特有的认知和行为症状往往给患者及其家属带来极大的压力。在这项发展研究中提出的干预措施是基于大量证据,即初级保健医生需要其他卫生保健从业人员的帮助,以满足从诊断开始的患者和家庭的需求。需要以证据为基础、有理论依据的干预措施,从诊断时起或之后尽快采取积极主动的方式,加强初级保健环境中的痴呆症护理,以避免或减轻患者及其家庭照顾者的不良健康相关结果。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Richard H Fortinsky其他文献

Real-World Insights Into Dementia Diagnosis Trajectory and Clinical Practice Patterns Unveiled by Natural Language Processing: Development and Usability Study
通过自然语言处理揭示的痴呆症诊断轨迹和临床实践模式的真实世界见解:开发和可用性研究
  • DOI:
    10.2196/65221
  • 发表时间:
    2025-01-01
  • 期刊:
  • 影响因子:
    4.800
  • 作者:
    Hunki Paek;Richard H Fortinsky;Kyeryoung Lee;Liang-Chin Huang;Yazeed S Maghaydah;George A Kuchel;Xiaoyan Wang
  • 通讯作者:
    Xiaoyan Wang

Richard H Fortinsky的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Richard H Fortinsky', 18)}}的其他基金

Data Core RC2
数据核心 RC2
  • 批准号:
    10294031
  • 财政年份:
    2021
  • 资助金额:
    $ 16.99万
  • 项目类别:
Claude D. Pepper Older Americans Independence Center (P30 Clinical Trial Optional)
Claude D. Pepper 美国老年人独立中心(P30 临床试验可选)
  • 批准号:
    10294028
  • 财政年份:
    2021
  • 资助金额:
    $ 16.99万
  • 项目类别:
Claude D. Pepper Older Americans Independence Center (P30 Clinical Trial Optional)
Claude D. Pepper 美国老年人独立中心(P30 临床试验可选)
  • 批准号:
    10668310
  • 财政年份:
    2021
  • 资助金额:
    $ 16.99万
  • 项目类别:
Data Core RC2
数据核心 RC2
  • 批准号:
    10668322
  • 财政年份:
    2021
  • 资助金额:
    $ 16.99万
  • 项目类别:
Impact of AD/ADRD on Health-Related Outcomes in a Statewide Population Enrolled in a Publicly-Funded HCBS Waiver Program for Older Adults
AD/ADRD 对参加公共资助的老年人 HCBS 豁免计划的全州人口健康相关结果的影响
  • 批准号:
    10095054
  • 财政年份:
    2020
  • 资助金额:
    $ 16.99万
  • 项目类别:
Translation of COPE for Publicly-Funded Home Care Clients and their Families
为公共资助的家庭护理客户及其家人提供 COPE 翻译
  • 批准号:
    9105676
  • 财政年份:
    2014
  • 资助金额:
    $ 16.99万
  • 项目类别:
Translation of COPE for Publicly-Funded Home Care Clients and their Families
为公共资助的家庭护理客户及其家人提供 COPE 翻译
  • 批准号:
    8696260
  • 财政年份:
    2014
  • 资助金额:
    $ 16.99万
  • 项目类别:
Translation of COPE for Publicly-Funded Home Care Clients and their Families
为公共资助的家庭护理客户及其家人提供 COPE 翻译
  • 批准号:
    8895825
  • 财政年份:
    2014
  • 资助金额:
    $ 16.99万
  • 项目类别:
RESOURCE USE AND PATIENT OUTCOMES IN MEDICARE HOME CARE
医疗保险家庭护理中的资源使用和患者结果
  • 批准号:
    6040884
  • 财政年份:
    1999
  • 资助金额:
    $ 16.99万
  • 项目类别:
RESOURCE USE AND PATIENT OUTCOMES IN MEDICARE HOME CARE
医疗保险家庭护理中的资源使用和患者结果
  • 批准号:
    6187610
  • 财政年份:
    1999
  • 资助金额:
    $ 16.99万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 16.99万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 16.99万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.99万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.99万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 16.99万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.99万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 16.99万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 16.99万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 16.99万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.99万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了